Genprex, Inc.
GNPX · XNASCIK 1595248fmd_0G9RCB901JMYWT1YWKZZEN4HNGManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2016 to Jun 30, 2026, 40 periods
Latest annual · FY2024
Millions- Total revenues
- 0
- Operating income
- (16)
- Net income
- (16)
Latest quarter · Q2 FY2026
Millions- Operating income
- (4)
- Net income
- (4)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2021 to FY2024
- n/m
- Net income, 5 yearsFY2020 to FY2025
- n/m
Genprex, Inc. (GNPX) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Operating income | -$15.5 million | -$21.2 million | 10-K 2026-03-30 · proof | |
| Net income | -$16.2 million | -$21.1 million | 10-K 2026-03-30 · proof | |
| Cash from operating activities | -$15.3 million | -$17.9 million | 10-K 2026-03-30 · proof | |
| Total assets | $10.2 million | $4.1 million | +146.3% | 10-K 2026-03-30 · proof |
| Total liabilities | $2.2 million | $2.5 million | -12.3% | 10-Q 2026-05-13 · proof |
| Cash and cash equivalents | $7.8 million | $1.6 million | +388.9% | 10-K 2026-03-30 · proof |
- What was Genprex, Inc. (GNPX)'s operating income in fiscal 2025?
- Genprex, Inc. (GNPX) reported operating income of -$15.5 million for fiscal 2025 (the year ended Dec 31, 2025), against -$21.2 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What was Genprex, Inc. (GNPX)'s net income in fiscal 2025?
- Genprex, Inc. (GNPX) reported net income of -$16.2 million for fiscal 2025 (the year ended Dec 31, 2025), against -$21.1 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What was Genprex, Inc. (GNPX)'s cash from operating activities in fiscal 2025?
- Genprex, Inc. (GNPX) reported cash from operating activities of -$15.3 million for fiscal 2025 (the year ended Dec 31, 2025), against -$17.9 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What are Genprex, Inc. (GNPX)'s total assets?
- As of Dec 31, 2025, Genprex, Inc. (GNPX) reported total assets of $10.2 million, against $4.1 million a year earlier (+146.3%). Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
- What are Genprex, Inc. (GNPX)'s total liabilities?
- As of Dec 31, 2025, Genprex, Inc. (GNPX) reported total liabilities of $2.2 million, against $2.5 million a year earlier (-12.3%). Source: the 10-Q filed with the SEC on May 13, 2026 (restated). SEC
- What are Genprex, Inc. (GNPX)'s cash and cash equivalents?
- As of Dec 31, 2025, Genprex, Inc. (GNPX) reported cash and cash equivalents of $7.8 million, against $1.6 million a year earlier (+388.9%). Source: the 10-K filed with the SEC on Mar 30, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:GNPX&period_type=annual&limit=5"Information only, not investment advice.